MTCM
BIIB icon

Mint Tower Capital Management’s Biogen BIIB Stock Holding History

Mint Tower Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,175
Closed -$314K – 260
2020
Q2 		$314K Buy
+1,175
New +$353K 0.04% 184

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Mint Tower Capital Management's BIIB Position: Q3 2020 in Review

Mint Tower Capital Management sold out of Biogen (BIIB) in Q3 2020, closing a stake of 1,175 shares — an estimated $314K sold.

Mint Tower Capital Management first reported a position in BIIB in Q2 2020 and held it in 1 quarter. The position peaked at $314K in Q2 2020. 1,051 funds tracked by Wall St. Rank hold BIIB as of Q3 2020.

  • Mint Tower Capital Management reported no remaining Biogen position as of Q3 2020 after selling out during the quarter.
  • Mint Tower Capital Management sold 1,175 Biogen shares in Q3 2020, an estimated $314K.
  • Mint Tower Capital Management first reported a position in Biogen in Q2 2020 and held it in 1 quarter.
  • Mint Tower Capital Management's Biogen position peaked at $314K in Q2 2020.
  • 1,051 funds tracked by Wall St. Rank held Biogen as of Q3 2020.

Based on Mint Tower Capital Management's 13F filing for Q3 2020, filed 10 Nov 2020.